Suppr超能文献

[阿莫沙平与洛沙平对大鼠脑内各种受体的亲和力比较及长期给药后的受体下调]

[Comparison of the affinities of amoxapine and loxapine for various receptors in rat brain and the receptor down-regulation after chronic administration].

作者信息

Wei H B, Niu X Y

机构信息

Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing.

出版信息

Yao Xue Xue Bao. 1990;25(12):881-5.

PMID:1966571
Abstract

Using radioligand receptor binding methods, the affinities (Ki) of amoxapine and loxapine for various receptors (adrenergic alpha 1, alpha 2, beta; dopaminergic D1, D2; serotoninergic 5-HT1, 5-HT2; Muscarinic, GABA, BZ) were investigated. The two compounds showed high affinities for 5-HT2, D2 and alpha 1 receptors (Ki less than 10(-7) mol/L), moderate affinity for alpha 2 receptor (Ki less than 10(-6) mol/L), and low affinities for M and 5-HT1 receptor (Ki less than 10(-5) mol/L). In addition, amoxapine appeared to have low affinities for D1 and GABA receptors. For D1 receptor, loxapine was found to have moderate affinity which was nearly 20 fold greater than amoxapine, but amoxapine exhibited more potent inhibitory effects on serotonin receptors and weaker inhibitory affects on dopamine receptors. Neither amoxapine nor loxapine showed significant affinity for BZ and beta-adrenergic receptors. These differences in the affinities may be responsible for their different psychopharmacological effects in the clinical treatment of patients. The regulation of 5-HT2 and beta receptors were examined in chronic experiments on rats given amoxapine 8 mg/kg or loxapine 1 mg/kg orally once daily for one to three weeks. The 5-HT2 receptor density was time-dependently reduced but no effect on beta receptors was observed. The down-regulation of 5-HT2 receptors might be associated with antidepressant action of the two drugs.

摘要

采用放射性配体受体结合方法,研究了阿莫沙平和洛沙平对各种受体(肾上腺素能α1、α2、β;多巴胺能D1、D2;5-羟色胺能5-HT1、5-HT2;毒蕈碱、GABA、苯二氮卓)的亲和力(Ki)。这两种化合物对5-HT2、D2和α1受体表现出高亲和力(Ki小于10^(-7)mol/L),对α2受体具有中等亲和力(Ki小于10^(-6)mol/L),对M和5-HT1受体具有低亲和力(Ki小于10^(-5)mol/L)。此外,阿莫沙平对D1和GABA受体似乎具有低亲和力。对于D1受体,发现洛沙平具有中等亲和力,几乎比阿莫沙平高20倍,但阿莫沙平对5-羟色胺受体表现出更强的抑制作用,对多巴胺受体的抑制作用较弱。阿莫沙平和洛沙平均未显示出对苯二氮卓和β-肾上腺素能受体的显著亲和力。这些亲和力的差异可能是它们在患者临床治疗中产生不同精神药理作用的原因。在对大鼠进行的慢性实验中,每天口服一次8mg/kg阿莫沙平或1mg/kg洛沙平,持续一至三周,检测5-HT2和β受体的调节情况。5-HT2受体密度随时间依赖性降低,但未观察到对β受体有影响。5-HT2受体的下调可能与这两种药物的抗抑郁作用有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验